Zymeworks, Inc. (ZYME)
29.81
+0.40
(+1.36%)
USD |
NASDAQ |
Sep 01, 14:54
Zymeworks Total Long Term Debt (Quarterly) : 265.33M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 265.33M |
| March 31, 2026 | 260.27M |
| December 31, 2025 | 14.80M |
| September 30, 2025 | 15.50M |
| June 30, 2025 | 15.09M |
| March 31, 2025 | 15.20M |
| December 31, 2024 | 15.77M |
| September 30, 2024 | 17.31M |
| June 30, 2024 | 17.22M |
| March 31, 2024 | 21.07M |
| December 31, 2023 | 22.46M |
| September 30, 2023 | 22.53M |
| June 30, 2023 | 23.61M |
| March 31, 2023 | 23.97M |
| December 31, 2022 | 24.79M |
| September 30, 2022 | 25.49M |
| June 30, 2022 | 29.28M |
| March 31, 2022 | 30.72M |
| December 31, 2021 | 31.04M |
| September 30, 2021 | 28.87M |
| June 30, 2021 | 30.22M |
| March 31, 2021 | 5.469M |
| December 31, 2020 | 5.951M |
| September 30, 2020 | 6.11M |
| June 30, 2020 | 6.684M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.358M |
| December 31, 2019 | 5.655M |
| September 30, 2019 | 5.899M |
| June 30, 2019 | 6.219M |
| March 31, 2019 | 6.459M |
| December 31, 2018 | 0.057M |
| September 30, 2018 | 0.062M |
| June 30, 2018 | 0.065M |
| March 31, 2018 | 0.067M |
| December 31, 2017 | 0.062M |
| September 30, 2017 | 0.01M |
| June 30, 2017 | 0.01M |
| March 31, 2017 | 4.525M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 60.57M |
| BridgeBio Pharma, Inc. | 3.370B |
| Aprea Therapeutics, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |